FDA propose drug label changes for use in pregnancy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2008年 / 1205卷 / 1期

关键词：

Pregnant Woman; Potential Risk; Healthcare Professional; Prescription Medication; Biological Product;

D O I：

10.2165/00128415-200812050-00001

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1 / 1

相关论文

共 50 条

[21] Multiple drugsLack of efficacy, off-label use and drug exposure during pregnancy
Reactions Weekly, 2024, 1999 (1) : 289 - 289
[22] FDA lifts pregnancy-related warnings from lubiprostone label
Reactions Weekly, 2013, 1433 (1) : 3 - 3
[23] The FDA Proposes Revisions to Pregnancy Information in Drug Labeling
Aschenbrenner, Diane S.
AMERICAN JOURNAL OF NURSING, 2008, 108 (11) : 32 - 34
[24] Extra label drug use
Rumney, HJ
CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 1997, 38 (05): : 261 - 261
[25] Impact of Drug Label Changes on Propofol Use in Pediatrics for Moderate Conscious Sedation
Heaton, Pamela C.
Schuchter, Joseph
Lannon, Carole M.
Kemper, Alex R.
CLINICAL THERAPEUTICS, 2011, 33 (07) : 886 - 895
[26] The FDA and drug safety - A proposal for sweeping changes
Furberg, Curt D.
Levin, Arthur A.
Gross, Peter A.
Shapiro, Robyn S.
Strom, Brian L.
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (18) : 1938 - 1942
[27] FDA proposes changes to ensure drug safety
Wechsler, Jill
FORMULARY, 2007, 42 (03) : 205 - 206
[28] FDA requests label changes for all sleep disorder medications
Naccari, Christopher
CNS SPECTRUMS, 2007, 12 (04) : 262 - 262
[29] US FDA approves label changes for GAs, sedatives in children
Reactions Weekly, 2017, 1651 (1) : 5 - 5
[30] Pregnancy and drug use
Reactions Weekly, 2001, 843 (1) : 4 - 4

← 1 2 3 4 5 →